{"id": "article-89667_0", "title": "Plantar Fibromatosis -- Continuing Education Activity", "content": "Plantar fibromatosis, also known as Ledderhose disease, is a benign proliferative foot disorder manifesting as fibrous overgrowth of the superficial plantar aponeurosis. Ledderhose disease is diagnosed by identifying nodules within the plantar fascia's central or medial bands. These nodules can vary in size from small pea-sized lumps to larger, more noticeable masses in the arch area. The disease is locally aggressive, leading to pain and swelling in the foot's medial, non-weight-bearing plantar surface. The exact cause of plantar fibromatosis is not fully understood, but a combination of genetic factors, trauma, plantar fascia injury, and medical conditions such as Dupuytren contracture is believed to give rise to this condition.", "contents": "Plantar Fibromatosis -- Continuing Education Activity. Plantar fibromatosis, also known as Ledderhose disease, is a benign proliferative foot disorder manifesting as fibrous overgrowth of the superficial plantar aponeurosis. Ledderhose disease is diagnosed by identifying nodules within the plantar fascia's central or medial bands. These nodules can vary in size from small pea-sized lumps to larger, more noticeable masses in the arch area. The disease is locally aggressive, leading to pain and swelling in the foot's medial, non-weight-bearing plantar surface. The exact cause of plantar fibromatosis is not fully understood, but a combination of genetic factors, trauma, plantar fascia injury, and medical conditions such as Dupuytren contracture is believed to give rise to this condition."}
{"id": "article-89667_1", "title": "Plantar Fibromatosis -- Continuing Education Activity", "content": "This activity for healthcare professionals is designed to enhance the learner's competence when diagnosing and managing plantar fibromatosis. After participation, clinicians exhibit improved proficiency in recognizing early signs, understanding treatment complexities, and implementing evidence-based strategies, ultimately optimizing patient outcomes for this challenging condition.", "contents": "Plantar Fibromatosis -- Continuing Education Activity. This activity for healthcare professionals is designed to enhance the learner's competence when diagnosing and managing plantar fibromatosis. After participation, clinicians exhibit improved proficiency in recognizing early signs, understanding treatment complexities, and implementing evidence-based strategies, ultimately optimizing patient outcomes for this challenging condition."}
{"id": "article-89667_2", "title": "Plantar Fibromatosis -- Continuing Education Activity", "content": "Objectives: Identify the risk factors for developing plantar fibromatosis. Create a clinically guided diagnostic strategy for a patient with suspected\u00a0plantar fibromatosis. Develop an individualized management plan for a patient diagnosed with\u00a0plantar fibromatosis. Implement communication strategies to enhance collaboration within an interprofessional team caring for individuals with plantar fibromatosis, especially when formulating short- and long-term treatments to improve quality of life and outcomes. Access free multiple choice questions on this topic.", "contents": "Plantar Fibromatosis -- Continuing Education Activity. Objectives: Identify the risk factors for developing plantar fibromatosis. Create a clinically guided diagnostic strategy for a patient with suspected\u00a0plantar fibromatosis. Develop an individualized management plan for a patient diagnosed with\u00a0plantar fibromatosis. Implement communication strategies to enhance collaboration within an interprofessional team caring for individuals with plantar fibromatosis, especially when formulating short- and long-term treatments to improve quality of life and outcomes. Access free multiple choice questions on this topic."}
{"id": "article-89667_3", "title": "Plantar Fibromatosis -- Introduction", "content": "Plantar fibromatosis is a benign, fibroblastic, proliferative connective tissue disorder of the superficial plantar aponeurosis. This condition, also known as Ledderhose disease, belongs to a family of similar diseases, including Peyronie and Dupuytren diseases, first described in 1610 by Plater. [1] George Ledderhose, a German physician, initially described the disorder in 1897 after observing 50 patients with painful sole lesions. [2]", "contents": "Plantar Fibromatosis -- Introduction. Plantar fibromatosis is a benign, fibroblastic, proliferative connective tissue disorder of the superficial plantar aponeurosis. This condition, also known as Ledderhose disease, belongs to a family of similar diseases, including Peyronie and Dupuytren diseases, first described in 1610 by Plater. [1] George Ledderhose, a German physician, initially described the disorder in 1897 after observing 50 patients with painful sole lesions. [2]"}
{"id": "article-89667_4", "title": "Plantar Fibromatosis -- Introduction", "content": "Ledderhose disease is diagnosed by identifying nodules within the central or medial plantar fascia bands. Patients with plantar fibromatosis often present with sole lumps, usually in the arch area. These masses may be singular or multiple and may occur unilaterally or bilaterally. Onset is slow, and patients usually present with pain and swelling in the medial, non-weight-bearing plantar foot surfaces after the disease becomes locally aggressive. [3]", "contents": "Plantar Fibromatosis -- Introduction. Ledderhose disease is diagnosed by identifying nodules within the central or medial plantar fascia bands. Patients with plantar fibromatosis often present with sole lumps, usually in the arch area. These masses may be singular or multiple and may occur unilaterally or bilaterally. Onset is slow, and patients usually present with pain and swelling in the medial, non-weight-bearing plantar foot surfaces after the disease becomes locally aggressive. [3]"}
{"id": "article-89667_5", "title": "Plantar Fibromatosis -- Introduction", "content": "The plantar aponeurosis (plantar fascia) is a thick connective tissue band supporting the foot arch composed primarily of collagen fibers arranged in a dense, fibrous matrix. This fibrous structure extends from the heel bone (calcaneus) to the toe bases and helps absorb shock during walking and running (see Image . Plantar Aponeurosis). The plantar fascia is divided into 3 distinct bands: medial, central, and lateral. The medial band is the thickest and strongest portion, while the lateral band is thinner and less prominent. These bands work together to distribute forces evenly across the foot and maintain the arches during movement. Additionally, the plantar fascia is richly supplied with blood vessels and nerves, contributing to its ability to heal and transmit sensory information.", "contents": "Plantar Fibromatosis -- Introduction. The plantar aponeurosis (plantar fascia) is a thick connective tissue band supporting the foot arch composed primarily of collagen fibers arranged in a dense, fibrous matrix. This fibrous structure extends from the heel bone (calcaneus) to the toe bases and helps absorb shock during walking and running (see Image . Plantar Aponeurosis). The plantar fascia is divided into 3 distinct bands: medial, central, and lateral. The medial band is the thickest and strongest portion, while the lateral band is thinner and less prominent. These bands work together to distribute forces evenly across the foot and maintain the arches during movement. Additionally, the plantar fascia is richly supplied with blood vessels and nerves, contributing to its ability to heal and transmit sensory information."}
{"id": "article-89667_6", "title": "Plantar Fibromatosis -- Introduction", "content": "In plantar fibromatosis, nodules or fibrous growths may develop within the plantar fascia, typically in the foot's central or medial portion, leading to pain, discomfort, and limited mobility. Adjacent anatomical structures relevant to plantar fibromatosis include the foot muscles and tendons, such as the flexor digitorum brevis and abductor hallucis, which interact closely with the plantar fascia. Nerves supplying sensory information to the foot, such as the medial and lateral plantar nerves, and blood vessels providing oxygen and nutrients to the tissues are also important considerations in the anatomy of plantar fibromatosis.", "contents": "Plantar Fibromatosis -- Introduction. In plantar fibromatosis, nodules or fibrous growths may develop within the plantar fascia, typically in the foot's central or medial portion, leading to pain, discomfort, and limited mobility. Adjacent anatomical structures relevant to plantar fibromatosis include the foot muscles and tendons, such as the flexor digitorum brevis and abductor hallucis, which interact closely with the plantar fascia. Nerves supplying sensory information to the foot, such as the medial and lateral plantar nerves, and blood vessels providing oxygen and nutrients to the tissues are also important considerations in the anatomy of plantar fibromatosis."}
{"id": "article-89667_7", "title": "Plantar Fibromatosis -- Etiology", "content": "The exact etiology leading to plantar fibromatosis is unknown. [4] However, repetitive trauma, genetics, medications, alcohol abuse, diabetes mellitus, and other proliferative disorders\u00a0appear to be associated with plantar fibromatosis. [5]", "contents": "Plantar Fibromatosis -- Etiology. The exact etiology leading to plantar fibromatosis is unknown. [4] However, repetitive trauma, genetics, medications, alcohol abuse, diabetes mellitus, and other proliferative disorders\u00a0appear to be associated with plantar fibromatosis. [5]"}
{"id": "article-89667_8", "title": "Plantar Fibromatosis -- Epidemiology", "content": "Plantar fibromatosis is rare, affecting less than 200,000 people in the United States.\u00a0The disorder\u00a0typically presents in middle-aged patients, most commonly in the 4th and 5th decades of life. However, cases involving children as young as 9 months have been reported.\u00a0The disease is\u00a0twice as likely to occur in male than female individuals and has an incidence of bilateral foot involvement in approximately 25% of patients.\u00a0Plantar fibromatosis is most common in patients with a history of diabetes, epilepsy, or alcohol use disorder.\u00a0A\u00a0familial inheritance pattern has been observed. Ledderhose disease shares a geographical similarity with Dupuytren hand contracture, as\u00a0plantar fibromatosis\u00a0is common\u00a0in people of northern European descent. [6] Patients with Dupuytren disease requiring surgery for hand deformity are more likely to have Ledderhose disease.", "contents": "Plantar Fibromatosis -- Epidemiology. Plantar fibromatosis is rare, affecting less than 200,000 people in the United States.\u00a0The disorder\u00a0typically presents in middle-aged patients, most commonly in the 4th and 5th decades of life. However, cases involving children as young as 9 months have been reported.\u00a0The disease is\u00a0twice as likely to occur in male than female individuals and has an incidence of bilateral foot involvement in approximately 25% of patients.\u00a0Plantar fibromatosis is most common in patients with a history of diabetes, epilepsy, or alcohol use disorder.\u00a0A\u00a0familial inheritance pattern has been observed. Ledderhose disease shares a geographical similarity with Dupuytren hand contracture, as\u00a0plantar fibromatosis\u00a0is common\u00a0in people of northern European descent. [6] Patients with Dupuytren disease requiring surgery for hand deformity are more likely to have Ledderhose disease."}
{"id": "article-89667_9", "title": "Plantar Fibromatosis -- Pathophysiology", "content": "Plantar fibromatosis has 3 stages. The 1st is a proliferative phase, where cell number increases in the plantar area. The 2nd stage is when the nodule forms. The\u00a03rd stage produces soft tissue scarring and mild contracture in the plantar foot.\u00a0The factors stimulating\u00a0the hyperactive proliferating fibroblasts involved in the disease process are unknown.\u00a0However,\u00a0an increased release of growth factors, such as\u00a0insulin-like growth factor-1, fibroblast growth factor,\u00a0platelet-derived growth factor, and\u00a0transforming growth factor-\u03b2, has been implicated. Increased interleukin-1-\u03b1 and \u03b2 have also been reported.", "contents": "Plantar Fibromatosis -- Pathophysiology. Plantar fibromatosis has 3 stages. The 1st is a proliferative phase, where cell number increases in the plantar area. The 2nd stage is when the nodule forms. The\u00a03rd stage produces soft tissue scarring and mild contracture in the plantar foot.\u00a0The factors stimulating\u00a0the hyperactive proliferating fibroblasts involved in the disease process are unknown.\u00a0However,\u00a0an increased release of growth factors, such as\u00a0insulin-like growth factor-1, fibroblast growth factor,\u00a0platelet-derived growth factor, and\u00a0transforming growth factor-\u03b2, has been implicated. Increased interleukin-1-\u03b1 and \u03b2 have also been reported."}
{"id": "article-89667_10", "title": "Plantar Fibromatosis -- Pathophysiology", "content": "A genetic component is present\u00a0in some cases. In a genome-wide association screen, 2 genetic variants were associated with plantar fibromatosis: one indel (chr5:118704153:D) and one single nucleotide polymorphism (rs62051384). Individuals with these variants may have an increased risk for plantar fibromatosis. [7]", "contents": "Plantar Fibromatosis -- Pathophysiology. A genetic component is present\u00a0in some cases. In a genome-wide association screen, 2 genetic variants were associated with plantar fibromatosis: one indel (chr5:118704153:D) and one single nucleotide polymorphism (rs62051384). Individuals with these variants may have an increased risk for plantar fibromatosis. [7]"}
{"id": "article-89667_11", "title": "Plantar Fibromatosis -- Histopathology", "content": "Proliferating fibroblasts produce the pathologic\u00a0plantar fascia nodules of plantar fibromatosis. These fibroblasts are found in areas surrounded by less cellular, modestly collagenous fascia.\u00a0The cells are the same size, randomly arranged in a matrix, and have\u00a0little vascular supply. The extracellular matrix and cytoskeleton have\u00a0abundant fibronectin and myofibroblasts\u00a0and a predominance of type III collagen. [8]", "contents": "Plantar Fibromatosis -- Histopathology. Proliferating fibroblasts produce the pathologic\u00a0plantar fascia nodules of plantar fibromatosis. These fibroblasts are found in areas surrounded by less cellular, modestly collagenous fascia.\u00a0The cells are the same size, randomly arranged in a matrix, and have\u00a0little vascular supply. The extracellular matrix and cytoskeleton have\u00a0abundant fibronectin and myofibroblasts\u00a0and a predominance of type III collagen. [8]"}
{"id": "article-89667_12", "title": "Plantar Fibromatosis -- History and Physical", "content": "The classic plantar fibromatosis presentation is a slow-growing nodule in the foot's medial or central plantar aponeurosis about 0.5 to 3 cm in diameter.\u00a0The nodule\u00a0may be single or multiple. Smaller nodules can\u00a0produce\u00a0areas of local pressure\u00a0or plantar distension.\u00a0Progressive\u00a0local invasion\u00a0can lead to worsening pain, swelling, and weight-bearing and ambulating difficulties. Patients commonly present\u00a0with intolerable foot sole pain after walking or standing for long periods.\u00a0Direct pressure on the nodule or medial foot arch, eg, when barefoot on hard floors or wearing shoes with inflexible insoles, may exacerbate symptoms.", "contents": "Plantar Fibromatosis -- History and Physical. The classic plantar fibromatosis presentation is a slow-growing nodule in the foot's medial or central plantar aponeurosis about 0.5 to 3 cm in diameter.\u00a0The nodule\u00a0may be single or multiple. Smaller nodules can\u00a0produce\u00a0areas of local pressure\u00a0or plantar distension.\u00a0Progressive\u00a0local invasion\u00a0can lead to worsening pain, swelling, and weight-bearing and ambulating difficulties. Patients commonly present\u00a0with intolerable foot sole pain after walking or standing for long periods.\u00a0Direct pressure on the nodule or medial foot arch, eg, when barefoot on hard floors or wearing shoes with inflexible insoles, may exacerbate symptoms."}
{"id": "article-89667_13", "title": "Plantar Fibromatosis -- History and Physical", "content": "Physical examination\u00a0of the foot and ankle\u00a0should include visual assessment, soft tissue and bone palpation, and range of motion\u00a0and gait evaluation. Plantar fibromas are typically visible or palpable.\u00a0A few patients\u00a0may\u00a0present with toe contractures, particularly at the big toe. [9] Ledderhose disease can affect 15% of individuals with Dupuytren contracture. Thus, hand examination is also paramount.", "contents": "Plantar Fibromatosis -- History and Physical. Physical examination\u00a0of the foot and ankle\u00a0should include visual assessment, soft tissue and bone palpation, and range of motion\u00a0and gait evaluation. Plantar fibromas are typically visible or palpable.\u00a0A few patients\u00a0may\u00a0present with toe contractures, particularly at the big toe. [9] Ledderhose disease can affect 15% of individuals with Dupuytren contracture. Thus, hand examination is also paramount."}
{"id": "article-89667_14", "title": "Plantar Fibromatosis -- Evaluation", "content": "Diagnosis is made based on the patient's history and physical exam. However, imaging and biopsy may be helpful for confirmation.\u00a0Appropriate imaging studies include magnetic resonance imaging (MRI) and ultrasound.", "contents": "Plantar Fibromatosis -- Evaluation. Diagnosis is made based on the patient's history and physical exam. However, imaging and biopsy may be helpful for confirmation.\u00a0Appropriate imaging studies include magnetic resonance imaging (MRI) and ultrasound."}
{"id": "article-89667_15", "title": "Plantar Fibromatosis -- Evaluation", "content": "On MRI, a plantar fibroma may appear as a focal, round area or lobulated, disorganized tissue in the plantar fascia with low signal intensity or a signal similar to muscle. [10] Nodules appear well-defined, with signal intensity low on T1 images and low to moderate on T2 images. MRI with contrast, such as gadolinium, may enhance the nodules' intensity. MRI may be obtained for excision planning and identifying the plantar contractures' extent.", "contents": "Plantar Fibromatosis -- Evaluation. On MRI, a plantar fibroma may appear as a focal, round area or lobulated, disorganized tissue in the plantar fascia with low signal intensity or a signal similar to muscle. [10] Nodules appear well-defined, with signal intensity low on T1 images and low to moderate on T2 images. MRI with contrast, such as gadolinium, may enhance the nodules' intensity. MRI may be obtained for excision planning and identifying the plantar contractures' extent."}
{"id": "article-89667_16", "title": "Plantar Fibromatosis -- Evaluation", "content": "Ultrasound can show the nodule depth, size, and number. Nodules typically appear isoechoic and heterogenous on ultrasound. Hyperechoic septa may also be present. Vascular flow is not usually appreciable when using Doppler ultrasound. [11] Ultrasound is a time- and cost-efficient modality, providing physicians with a quick office diagnostic tool during the patient\u2019s appointment. X-rays may be obtained to rule out underlying bony pathology or soft tissue calcifications contributing to the symptoms. A biopsy may be utilized to rule out malignancy. [17]", "contents": "Plantar Fibromatosis -- Evaluation. Ultrasound can show the nodule depth, size, and number. Nodules typically appear isoechoic and heterogenous on ultrasound. Hyperechoic septa may also be present. Vascular flow is not usually appreciable when using Doppler ultrasound. [11] Ultrasound is a time- and cost-efficient modality, providing physicians with a quick office diagnostic tool during the patient\u2019s appointment. X-rays may be obtained to rule out underlying bony pathology or soft tissue calcifications contributing to the symptoms. A biopsy may be utilized to rule out malignancy. [17]"}
{"id": "article-89667_17", "title": "Plantar Fibromatosis -- Treatment / Management -- Treatment Mainstays: Nonoperative Modalities", "content": "Multiple nonoperative treatments for plantar fibromatosis have been described. These modalities primarily focus on symptom reduction rather than nodule removal or disease progression prevention. The treatment mainstays are anti-inflammatories, physical therapy, and shoe wear or activity modifications. Adjunctive interventions are explained below.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Treatment Mainstays: Nonoperative Modalities. Multiple nonoperative treatments for plantar fibromatosis have been described. These modalities primarily focus on symptom reduction rather than nodule removal or disease progression prevention. The treatment mainstays are anti-inflammatories, physical therapy, and shoe wear or activity modifications. Adjunctive interventions are explained below."}
{"id": "article-89667_18", "title": "Plantar Fibromatosis -- Treatment / Management -- Orthotics or pads", "content": "Patients with mild disease and minimal symptoms can place pads inside the shoe to offload the fibromatous foot parts. Increased internal shoe padding can also help alleviate symptoms like mild discomfort. [12] Carbon footplates or rocker bottom shoes may also decrease the stress across the plantar fascia.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Orthotics or pads. Patients with mild disease and minimal symptoms can place pads inside the shoe to offload the fibromatous foot parts. Increased internal shoe padding can also help alleviate symptoms like mild discomfort. [12] Carbon footplates or rocker bottom shoes may also decrease the stress across the plantar fascia."}
{"id": "article-89667_19", "title": "Plantar Fibromatosis -- Treatment / Management -- Steroids", "content": "Few studies support steroid use in plantar fibromatosis, though these medications are proven beneficial in Dupuytren disease. Local steroid injection helps reduce plantar fascia node and strand size. Steroids are thought to decrease fibroblast activity and accelerate their apoptosis. These agents reduce VCAM1 expression, limiting proinflammatory cytokine production, inflammation, and nodule growth. Size reduction can occur over a few months. Complications due to steroid injections include fascial or tendon rupture, fat atrophy, and skin depigmentation. [13]", "contents": "Plantar Fibromatosis -- Treatment / Management -- Steroids. Few studies support steroid use in plantar fibromatosis, though these medications are proven beneficial in Dupuytren disease. Local steroid injection helps reduce plantar fascia node and strand size. Steroids are thought to decrease fibroblast activity and accelerate their apoptosis. These agents reduce VCAM1 expression, limiting proinflammatory cytokine production, inflammation, and nodule growth. Size reduction can occur over a few months. Complications due to steroid injections include fascial or tendon rupture, fat atrophy, and skin depigmentation. [13]"}
{"id": "article-89667_20", "title": "Plantar Fibromatosis -- Treatment / Management -- Collagenase", "content": "Clostridium histolyticum\u2013 derived collagenase is used to break down collagen. Collagenase injections have been used in treating Peyronie and Dupuytren diseases, but the evidence for this modality's effectiveness in plantar fibromatosis is limited.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Collagenase. Clostridium histolyticum\u2013 derived collagenase is used to break down collagen. Collagenase injections have been used in treating Peyronie and Dupuytren diseases, but the evidence for this modality's effectiveness in plantar fibromatosis is limited."}
{"id": "article-89667_21", "title": "Plantar Fibromatosis -- Treatment / Management -- Collagenase", "content": "Pentland et al described a case of a patient presenting with difficulty ambulating due to plantar fibroma pain. Monthly C histolyticum collagenase injections were performed off-label over 5 months. The patient was able to resume jogging 4 months following the last injection.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Collagenase. Pentland et al described a case of a patient presenting with difficulty ambulating due to plantar fibroma pain. Monthly C histolyticum collagenase injections were performed off-label over 5 months. The patient was able to resume jogging 4 months following the last injection."}
{"id": "article-89667_22", "title": "Plantar Fibromatosis -- Treatment / Management -- Collagenase", "content": "Meanwhile, Lehrman et al described a case report about treating a patient with recurrent plantar fibromas with collagenase injection. [14] The patient had failed conservative treatment and multiple surgical interventions before attempting collagenase therapy. Collagenase was injected into the fibroma in the following manner: a third of the solution was administered centrally, another third proximally, and the last third distally. The patient was brought back to the clinic 24 hours after the injection for fibroma fragmentation by plantar massage and passive range of motion exercises. The symptoms were reported to resolve at the last follow-up, 33 months after the intervention.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Collagenase. Meanwhile, Lehrman et al described a case report about treating a patient with recurrent plantar fibromas with collagenase injection. [14] The patient had failed conservative treatment and multiple surgical interventions before attempting collagenase therapy. Collagenase was injected into the fibroma in the following manner: a third of the solution was administered centrally, another third proximally, and the last third distally. The patient was brought back to the clinic 24 hours after the injection for fibroma fragmentation by plantar massage and passive range of motion exercises. The symptoms were reported to resolve at the last follow-up, 33 months after the intervention."}
{"id": "article-89667_23", "title": "Plantar Fibromatosis -- Treatment / Management -- Verapamil", "content": "Verapamil is a calcium channel blocker commonly used as an antihypertensive. Verapamil has also been shown to promote collagenase activity and inhibit collagen production. Transdermal verapamil cream application and intralesional verapamil injection have demonstrated the ability to reduce fibroma size by 55% to 85%. Contact dermatitis is the most common complication of verapamil use.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Verapamil. Verapamil is a calcium channel blocker commonly used as an antihypertensive. Verapamil has also been shown to promote collagenase activity and inhibit collagen production. Transdermal verapamil cream application and intralesional verapamil injection have demonstrated the ability to reduce fibroma size by 55% to 85%. Contact dermatitis is the most common complication of verapamil use."}
{"id": "article-89667_24", "title": "Plantar Fibromatosis -- Treatment / Management -- Extracorporeal shock wave therapy", "content": "Extracorporeal shock wave therapy (ESWT) has been used to treat multiple foot and ankle conditions, such as plantar fasciitis, Achilles tendonitis, delayed fracture healing, and wound healing issues. ESWT is a noninvasive intervention that acts by transmitting shock waves to the treated tissue and provoking a biological response. An animal study revealed that ESWT may induce free radicals to produce growth factors and promote angiogenesis and inflammation reduction. These actions combined result in soft tissue and bone healing. [15]", "contents": "Plantar Fibromatosis -- Treatment / Management -- Extracorporeal shock wave therapy. Extracorporeal shock wave therapy (ESWT) has been used to treat multiple foot and ankle conditions, such as plantar fasciitis, Achilles tendonitis, delayed fracture healing, and wound healing issues. ESWT is a noninvasive intervention that acts by transmitting shock waves to the treated tissue and provoking a biological response. An animal study revealed that ESWT may induce free radicals to produce growth factors and promote angiogenesis and inflammation reduction. These actions combined result in soft tissue and bone healing. [15]"}
{"id": "article-89667_25", "title": "Plantar Fibromatosis -- Treatment / Management -- Extracorporeal shock wave therapy", "content": "ESWT treats Dupuytren and Peyronie diseases effectively, but its utility in plantar fibromatosis treatment lacks evidence. ESWT seems to reduce pain and soften the nodules without reducing plantar nodule size.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Extracorporeal shock wave therapy. ESWT treats Dupuytren and Peyronie diseases effectively, but its utility in plantar fibromatosis treatment lacks evidence. ESWT seems to reduce pain and soften the nodules without reducing plantar nodule size."}
{"id": "article-89667_26", "title": "Plantar Fibromatosis -- Treatment / Management -- Radiation therapy", "content": "Electron beam radiation is believed to decrease fibroblast activity by disrupting transforming growth factor-\u03b2 production. This mechanism may slow disease progression and be most effective during the early stages of plantar fibromatosis.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Radiation therapy. Electron beam radiation is believed to decrease fibroblast activity by disrupting transforming growth factor-\u03b2 production. This mechanism may slow disease progression and be most effective during the early stages of plantar fibromatosis."}
{"id": "article-89667_27", "title": "Plantar Fibromatosis -- Treatment / Management -- Radiation therapy", "content": "Treatment guidelines recommend weekly radiation doses for a total of 6 weeks. One study showed a complete node resolution in 33.3% of cases and decreased node size in 54.5%. Radiation therapy's side effects include erythema and dry skin. The incidence of malignant skin transformation is unknown, as treated cases lack long-term follow-up.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Radiation therapy. Treatment guidelines recommend weekly radiation doses for a total of 6 weeks. One study showed a complete node resolution in 33.3% of cases and decreased node size in 54.5%. Radiation therapy's side effects include erythema and dry skin. The incidence of malignant skin transformation is unknown, as treated cases lack long-term follow-up."}
{"id": "article-89667_28", "title": "Plantar Fibromatosis -- Treatment / Management -- Tamoxifen", "content": "Antiestrogen drug administration is still in the experimental phases as a possible treatment. Tamoxifen inhibits transforming growth factor-\u03b2 expression, thus suppressing fibroblast proliferation and maturation and myofibroblast differentiation. Studies have demonstrated this antiestrogen's promise in Dupuytren contracture treatment, with up to 20% nodule size regression. However, no studies have examined the use of estrogen receptor-modulating agents in plantar fibromatosis.", "contents": "Plantar Fibromatosis -- Treatment / Management -- Tamoxifen. Antiestrogen drug administration is still in the experimental phases as a possible treatment. Tamoxifen inhibits transforming growth factor-\u03b2 expression, thus suppressing fibroblast proliferation and maturation and myofibroblast differentiation. Studies have demonstrated this antiestrogen's promise in Dupuytren contracture treatment, with up to 20% nodule size regression. However, no studies have examined the use of estrogen receptor-modulating agents in plantar fibromatosis."}
{"id": "article-89667_29", "title": "Plantar Fibromatosis -- Differential Diagnosis", "content": "Care should be taken to exclude other diagnoses if a foot arch mass is causing pain. The differential diagnosis of such a lesion includes plantar fasciitis, tarsal tunnel syndrome, calcaneus fracture,\u00a0and tumor. Tumor types include leiomyoma, simple fibroma, liposarcoma, neurofibroma, rhabdomyosarcoma, fibrosarcoma, and nodular\u00a0fasciitis. Clinical history, imaging, and biopsy can differentiate between these conditions.", "contents": "Plantar Fibromatosis -- Differential Diagnosis. Care should be taken to exclude other diagnoses if a foot arch mass is causing pain. The differential diagnosis of such a lesion includes plantar fasciitis, tarsal tunnel syndrome, calcaneus fracture,\u00a0and tumor. Tumor types include leiomyoma, simple fibroma, liposarcoma, neurofibroma, rhabdomyosarcoma, fibrosarcoma, and nodular\u00a0fasciitis. Clinical history, imaging, and biopsy can differentiate between these conditions."}
{"id": "article-89667_30", "title": "Plantar Fibromatosis -- Surgical Oncology", "content": "The main surgical indications in plantar fibromatosis cases include conservative treatment refractoriness and compromise of daily activities, eg,\u00a0when ambulation difficulty or inability to fit in the usual shoe size develops. Standard surgical strategy options include: Local excision, which entails removing the entire nodule; recurrence rate is 60% to 100% Wide excision, which involves removing the nodule with 2 cm margins; recurrence rate is up to 60% Complete fasciectomy, which removes the plantar fascia; recurrence rate is 25% Sammarco and Mangone published an operative staging system taking into account the extent of plantar fascia involvement, skin adherence, and nodule depth.", "contents": "Plantar Fibromatosis -- Surgical Oncology. The main surgical indications in plantar fibromatosis cases include conservative treatment refractoriness and compromise of daily activities, eg,\u00a0when ambulation difficulty or inability to fit in the usual shoe size develops. Standard surgical strategy options include: Local excision, which entails removing the entire nodule; recurrence rate is 60% to 100% Wide excision, which involves removing the nodule with 2 cm margins; recurrence rate is up to 60% Complete fasciectomy, which removes the plantar fascia; recurrence rate is 25% Sammarco and Mangone published an operative staging system taking into account the extent of plantar fascia involvement, skin adherence, and nodule depth."}
{"id": "article-89667_31", "title": "Plantar Fibromatosis -- Surgical Oncology", "content": "Grade 1: has a focal lesion\u00a0but no extension and skin or muscle involvement Grade 2: involves multiple areas and can extend distally or proximally; has no skin or muscle encroachment Grade 3: involves multiple areas and can extend distally or proximally; has skin or muscle involvement Grade 4: encompasses multiple areas and can extend distally or proximally; involves both skin and muscle", "contents": "Plantar Fibromatosis -- Surgical Oncology. Grade 1: has a focal lesion\u00a0but no extension and skin or muscle involvement Grade 2: involves multiple areas and can extend distally or proximally; has no skin or muscle encroachment Grade 3: involves multiple areas and can extend distally or proximally; has skin or muscle involvement Grade 4: encompasses multiple areas and can extend distally or proximally; involves both skin and muscle"}
{"id": "article-89667_32", "title": "Plantar Fibromatosis -- Surgical Oncology", "content": "Local recurrence is the most common concern in any surgical treatment. Some consider total or complete fasciectomy to be the primary plantar fibromatosis surgical treatment since it seems to have the lowest recurrence. [16]", "contents": "Plantar Fibromatosis -- Surgical Oncology. Local recurrence is the most common concern in any surgical treatment. Some consider total or complete fasciectomy to be the primary plantar fibromatosis surgical treatment since it seems to have the lowest recurrence. [16]"}
{"id": "article-89667_33", "title": "Plantar Fibromatosis -- Surgical Oncology", "content": "A new endoscopic subtotal plantar fasciectomy technique has been described. This modality is indicated for recalcitrant fibromas. However, the treatment is contraindicated for nodules attaching superficially to the skin, invading deep foot musculature, or involving neurovasculature. [17] Compared to open excision, endoscopy is technically more challenging but results in better wound healing and minimal scarring due to the smaller incisions required.", "contents": "Plantar Fibromatosis -- Surgical Oncology. A new endoscopic subtotal plantar fasciectomy technique has been described. This modality is indicated for recalcitrant fibromas. However, the treatment is contraindicated for nodules attaching superficially to the skin, invading deep foot musculature, or involving neurovasculature. [17] Compared to open excision, endoscopy is technically more challenging but results in better wound healing and minimal scarring due to the smaller incisions required."}
{"id": "article-89667_34", "title": "Plantar Fibromatosis -- Surgical Oncology", "content": "Surgical planning should pay particular attention to incisions in weight-bearing areas. Longitudinal incisions can predispose the skin to hypertrophic scarring. Medial-to-midline transverse or zigzag incisions can put the skin at risk for necrosis due to plantar arterial supply disruption. [18]", "contents": "Plantar Fibromatosis -- Surgical Oncology. Surgical planning should pay particular attention to incisions in weight-bearing areas. Longitudinal incisions can predispose the skin to hypertrophic scarring. Medial-to-midline transverse or zigzag incisions can put the skin at risk for necrosis due to plantar arterial supply disruption. [18]"}
{"id": "article-89667_35", "title": "Plantar Fibromatosis -- Staging -- Stages of Disease", "content": "Plantar fibromatosis\u00a0development has the following stages: Proliferative phase: Increased fibroblast activity is observed. Active\u00a0or involution phase: Fibroblast\u00a0maturation, myofibroblast differentiation, and increased collagen production occur. Residual phase: Collagen and fibroblast maturation wane.", "contents": "Plantar Fibromatosis -- Staging -- Stages of Disease. Plantar fibromatosis\u00a0development has the following stages: Proliferative phase: Increased fibroblast activity is observed. Active\u00a0or involution phase: Fibroblast\u00a0maturation, myofibroblast differentiation, and increased collagen production occur. Residual phase: Collagen and fibroblast maturation wane."}
{"id": "article-89667_36", "title": "Plantar Fibromatosis -- Staging -- Sammarco and Mangone Classification", "content": "Severity\u00a0may be evaluated using the following grading scheme: Grade 1: has a focal lesion\u00a0but\u00a0no extension and skin or muscle involvement Grade 2: involves multiple areas and can extend distally or proximally; has no skin or muscle encroachment Grade 3: involves multiple areas and can extend distally or proximally; has skin or muscle involvement Grade 4: encompasses multiple areas and can extend distally or proximally; involves both skin and muscle", "contents": "Plantar Fibromatosis -- Staging -- Sammarco and Mangone Classification. Severity\u00a0may be evaluated using the following grading scheme: Grade 1: has a focal lesion\u00a0but\u00a0no extension and skin or muscle involvement Grade 2: involves multiple areas and can extend distally or proximally; has no skin or muscle encroachment Grade 3: involves multiple areas and can extend distally or proximally; has skin or muscle involvement Grade 4: encompasses multiple areas and can extend distally or proximally; involves both skin and muscle"}
{"id": "article-89667_37", "title": "Plantar Fibromatosis -- Prognosis", "content": "Ledderhose disease\u00a0may be treated\u00a0during the first office visit with conservative therapy. Surgery is reserved for patients with lesions\u00a0unresponsive to medical treatments or interfering with daily activities, such as wearing shoes or walking. Recurrence is high regardless if the treatment is nonoperative or operative.", "contents": "Plantar Fibromatosis -- Prognosis. Ledderhose disease\u00a0may be treated\u00a0during the first office visit with conservative therapy. Surgery is reserved for patients with lesions\u00a0unresponsive to medical treatments or interfering with daily activities, such as wearing shoes or walking. Recurrence is high regardless if the treatment is nonoperative or operative."}
{"id": "article-89667_38", "title": "Plantar Fibromatosis -- Complications", "content": "Untreated plantar fibromatosis' main complication is chronic pain due to continued lesion growth.\u00a0Additional complications include wound healing problems, hypertrophic scarring, and recurrence after treatment.\u00a0However, plantar fibromas are benign tumors\u00a0that do not usually have malignant potential.", "contents": "Plantar Fibromatosis -- Complications. Untreated plantar fibromatosis' main complication is chronic pain due to continued lesion growth.\u00a0Additional complications include wound healing problems, hypertrophic scarring, and recurrence after treatment.\u00a0However, plantar fibromas are benign tumors\u00a0that do not usually have malignant potential."}
{"id": "article-89667_39", "title": "Plantar Fibromatosis -- Complications", "content": "Surgery, particularly local excision, has high recurrence rates. Recurrence is\u00a0more frequent in patients with multiple lesions and positive family history. Besides recurrence, potential surgical complications include nerve entrapment and postoperative wound-related issues, such as dehiscence and painful scarring.\u00a0A\u00a0loss of medial longitudinal arch height has also been reported after\u00a0subtotal fasciectomy. Plantar nerve damage can lead to numbness or neuroma formation. [18]", "contents": "Plantar Fibromatosis -- Complications. Surgery, particularly local excision, has high recurrence rates. Recurrence is\u00a0more frequent in patients with multiple lesions and positive family history. Besides recurrence, potential surgical complications include nerve entrapment and postoperative wound-related issues, such as dehiscence and painful scarring.\u00a0A\u00a0loss of medial longitudinal arch height has also been reported after\u00a0subtotal fasciectomy. Plantar nerve damage can lead to numbness or neuroma formation. [18]"}
{"id": "article-89667_40", "title": "Plantar Fibromatosis -- Postoperative and Rehabilitation Care", "content": "After surgical intervention, the patient remains non-weight-bearing on the surgical side until the incision heals approximately 3 weeks later. After healing, full weight-bearing and return to activity are allowed.", "contents": "Plantar Fibromatosis -- Postoperative and Rehabilitation Care. After surgical intervention, the patient remains non-weight-bearing on the surgical side until the incision heals approximately 3 weeks later. After healing, full weight-bearing and return to activity are allowed."}
{"id": "article-89667_41", "title": "Plantar Fibromatosis -- Consultations", "content": "Plantar fibromatosis consultation should include the following: Podiatry Orthopedics Physical Therapy Orthotists Early intervention and treatment adherence can improve outcomes.", "contents": "Plantar Fibromatosis -- Consultations. Plantar fibromatosis consultation should include the following: Podiatry Orthopedics Physical Therapy Orthotists Early intervention and treatment adherence can improve outcomes."}
{"id": "article-89667_42", "title": "Plantar Fibromatosis -- Deterrence and Patient Education", "content": "Preventive measures for plantar fibromatosis focus on\u00a0minimizing risk factors and promoting foot health. These measures include the following: Keeping a healthy weight to reduce pressure on the feet Wearing properly fitting supportive footwear to distribute the load evenly and reduce strain on the plantar fascia Managing underlying conditions that may contribute to plantar fibromatosis development, such as diabetes mellitus and obesity Gradually increasing physical activity to allow the feet to adapt and limit the risk of overuse injuries Performing regular strengthening and stretching exercises to maintain foot stability and calf muscle and plantar fascia flexibility Regular foot care to avoid inflammatory foot conditions and prevent complications Patients must be advised to consult a healthcare professional promptly for persistent foot pain.", "contents": "Plantar Fibromatosis -- Deterrence and Patient Education. Preventive measures for plantar fibromatosis focus on\u00a0minimizing risk factors and promoting foot health. These measures include the following: Keeping a healthy weight to reduce pressure on the feet Wearing properly fitting supportive footwear to distribute the load evenly and reduce strain on the plantar fascia Managing underlying conditions that may contribute to plantar fibromatosis development, such as diabetes mellitus and obesity Gradually increasing physical activity to allow the feet to adapt and limit the risk of overuse injuries Performing regular strengthening and stretching exercises to maintain foot stability and calf muscle and plantar fascia flexibility Regular foot care to avoid inflammatory foot conditions and prevent complications Patients must be advised to consult a healthcare professional promptly for persistent foot pain."}
{"id": "article-89667_43", "title": "Plantar Fibromatosis -- Pearls and Other Issues", "content": "Plantar fibromatosis is a benign but highly recurrent connective tissue disorder\u00a0involving the superficial plantar aponeurosis. The cause is unknown, but risk factors for developing plantar fibromatosis include genetics, plantar fascia injury, and medical conditions such as Dupuytren contracture and diabetes mellitus. The diagnosis of this condition is clinically based, although imaging and biopsy can help rule out serious conditions such as cancer.", "contents": "Plantar Fibromatosis -- Pearls and Other Issues. Plantar fibromatosis is a benign but highly recurrent connective tissue disorder\u00a0involving the superficial plantar aponeurosis. The cause is unknown, but risk factors for developing plantar fibromatosis include genetics, plantar fascia injury, and medical conditions such as Dupuytren contracture and diabetes mellitus. The diagnosis of this condition is clinically based, although imaging and biopsy can help rule out serious conditions such as cancer."}
{"id": "article-89667_44", "title": "Plantar Fibromatosis -- Pearls and Other Issues", "content": "Management depends on symptom severity and individual needs. Conservative measures such as orthotics, physical therapy, and steroid injections may be effective in managing mild to moderate cases. Surgical excision may be considered for larger or more symptomatic nodules, although recurrence rates can be high. Chronic pain and limited mobility are the most common complications of plantar fibromatosis. Prompt identification and appropriate management can help minimize these complications and improve quality of life for affected individuals. Collaborative care can help optimize treatment outcomes and address the needs of patients with this condition.", "contents": "Plantar Fibromatosis -- Pearls and Other Issues. Management depends on symptom severity and individual needs. Conservative measures such as orthotics, physical therapy, and steroid injections may be effective in managing mild to moderate cases. Surgical excision may be considered for larger or more symptomatic nodules, although recurrence rates can be high. Chronic pain and limited mobility are the most common complications of plantar fibromatosis. Prompt identification and appropriate management can help minimize these complications and improve quality of life for affected individuals. Collaborative care can help optimize treatment outcomes and address the needs of patients with this condition."}
{"id": "article-89667_45", "title": "Plantar Fibromatosis -- Enhancing Healthcare Team Outcomes", "content": "Interprofessional care for patients with plantar fibromatosis may involve a team comprised of primary care physicians, podiatrists, orthopedic surgeons, physical therapists, pain specialists, orthotists, and nursing staff. Each team member functions according to the scope of their practice, working together to develop and implement a comprehensive care plan specific to individual needs.", "contents": "Plantar Fibromatosis -- Enhancing Healthcare Team Outcomes. Interprofessional care for patients with plantar fibromatosis may involve a team comprised of primary care physicians, podiatrists, orthopedic surgeons, physical therapists, pain specialists, orthotists, and nursing staff. Each team member functions according to the scope of their practice, working together to develop and implement a comprehensive care plan specific to individual needs."}
{"id": "article-89667_46", "title": "Plantar Fibromatosis -- Enhancing Healthcare Team Outcomes", "content": "Primary care physicians coordinate care with specialists, such as podiatrists and orthopedic surgeons, for specific interventions. Pain specialists may help manage chronic foot pain outpatient or provide anesthesia care during procedures. Physical therapists may assist with stretching the fascia and reducing the lesion size. Nursing may be involved in postoperative patient care. Orthotists help manage plantar fibromatosis by assessing foot mechanics and providing customized orthotic devices.", "contents": "Plantar Fibromatosis -- Enhancing Healthcare Team Outcomes. Primary care physicians coordinate care with specialists, such as podiatrists and orthopedic surgeons, for specific interventions. Pain specialists may help manage chronic foot pain outpatient or provide anesthesia care during procedures. Physical therapists may assist with stretching the fascia and reducing the lesion size. Nursing may be involved in postoperative patient care. Orthotists help manage plantar fibromatosis by assessing foot mechanics and providing customized orthotic devices."}
{"id": "article-89667_47", "title": "Plantar Fibromatosis -- Enhancing Healthcare Team Outcomes", "content": "The key components of interprofessional care for plantar fibromatosis include comprehensive assessment, treatment planning, care coordination, patient education, and continuity of care. By taking advantage of the expertise and resources of multiple disciplines, interprofessional care can enhance the quality, safety, and effectiveness of treatment for patients with plantar fibromatosis, ultimately improving patient outcomes and quality of life.", "contents": "Plantar Fibromatosis -- Enhancing Healthcare Team Outcomes. The key components of interprofessional care for plantar fibromatosis include comprehensive assessment, treatment planning, care coordination, patient education, and continuity of care. By taking advantage of the expertise and resources of multiple disciplines, interprofessional care can enhance the quality, safety, and effectiveness of treatment for patients with plantar fibromatosis, ultimately improving patient outcomes and quality of life."}
{"id": "article-89667_48", "title": "Plantar Fibromatosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Plantar Fibromatosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}